Luis Alvarez/DigitalVision via Getty Images
The U.S. Food and Drug Administration said on Thursday that it will be phasing out the animal testing requirement for monoclonal antibody therapies and other drugs, replacing it with more ethical methods like AI computations and human-based models.
In a